NeuroDyne’s products include medical instruments, sensors, disposable electrodes and software that offer sEMG, EKG, EEG, respiration, skin temp, EDR, EDL, peripheral blood flow, IBI, heart rate, and heart rate variability.

NeuroDyne’s devices are used to evaluate and treat neurological and neuromuscular disorders as well as provide education and research.

Zynex CEO Thomas Sandgaard said this acquisition is strategic for them, as they believe it will provide them to entrance into the neurodiagnostic market and will allow them to diversify their current product offerings.

NeuroDyne CEO Tahir Chaudhry said they believe that Zynex offers the platform to further advance the proven NeuroDyne product mix and accelerate the global reach into the neurodiagnostic market.